Twist Bioscience Corporation

    Jurisdiction
    United States
    LEI
    549300T23BL59LCOH584
    ISIN
    US90184D1000 (TWST)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    InsiderPie Expert Score
    57 / 100
    Even with peer group:
    57 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. Read full profile

    Fundamentals

    Net revenue
    €309.00M
    Gross margin
    49.2%
    EBIT
    -€121.43M
    EBIT margin
    -39.3%
    Net income
    -€72.66M
    Net margin
    -23.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €371.32M +20.2% -€69.89M -3.8%
    €430.25M +15.9% -€50.57M -27.6%
    €496.02M +15.3% -€11.43M -77.4%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    No dividend payouts

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    WERNER ROBERT F. Chief Accounting Officer -853 $27.69 -$23.62K
    Cho Dennis See Remarks -521 $25.96 -$13.53K
    Finn Patrick John President and COO -1.8K $25.96 -$47.77K
    Green Paula SVP of Human Resources -619 $25.96 -$16.07K
    Laponis Adam Chief Financial Officer -918 $25.96 -$23.83K

    Earnings Calls

    Investor transactions

    Name Shares Value Last change Change type
    Cathie Wood 6.2M $245.05M +646K Buy
    James Anderson 732K $28.74M -46K Sell
    Peter Brown 194K $7.61M -205K Sell

    Earnings Calls

    Latest earnings call: May 2, 2024 (Q2 2024)

    Add to watchlist

    Notifications